Drop Drinks creates vintage beverages with a distinctive taste. Theses beverages are inspired by traditional British sweets like Pear Drop and Cherry Drop. The company has sold more than 10,000 units since its launch in 2018. With more than 9,000 followers on social platforms such as Facebook and Instagram, Drop Drinks aims at increasing its product range to become a popular and leading drink brand domestically and grow globally. The company is now raising funds to increase production, execute an extensive go-to-market strategy, and hire key staff.
days to go:
Expired
investment:
£127,690
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.
days to go:
Expired
investment:
£49,990
Boundless Labs' Moodspace is an online learning platform for mental health treatment. It was commenced as a passion project between friends in 2014 later evolving into an application. The company takes established concepts from mental health therapy and re-imagines this teaching for a digital world, as daily mental health workouts. The platform has 5,400 monthly active members as of January 2020. Moodspace aims to teach the full breadth of therapy and empowers everyone to take control of their mental health. With the proceeds, the company will curate a wider breadth of mental health concepts and cultivate partnerships within the mental health ecosystem that includes building B2B relationships directly with therapists.
days to go:
Expired
investment:
£55,710
Nutrifix is an app that locates healthy meals nearby or selects recipes or delivery options all tailored to you bodies needs. The app is like having a personal nutritionist in your pocket and is in a growing sector as the global value of mobile health solutions is set to reach 83,000,000,000 by 2022.
days to go:
Expired
investment:
£194,310
Roqberry is a high-quality blended speciality tea made for millennial foodies. The company has received 20 Great Taste Awards and has secured listings with high-end distributors. It is stocked in speciality restaurants and retailers. Roqberry has been named as one of The Independent's "Best Plastic-Free Teabags". Already selling its products via its online shop and Amazon, the company is in discussion with other F&B chains, retailers and a major hotel. Roqberry is looking forward to scaling its B2B sales and B2C by hiring an account manager and new ops.
days to go:
Expired
investment:
£152,290
BioScore is a London-based health technology platform that enables you to easily visualize, track, and understand your fitness and health test results. It is currently designed as a software service for health and fitness professionals, gyms, personal trainers, sports coaches, sports clubs, schools, other allied health consultants and their clients. Leveraging on the trend of health optimization, BioScore aims to provide meaningful infographics and explanations, linked test histories, and personalised advice and action plans from fitness or health experts to their respective end-users, resulting in more effective diagnosis of ailments. The company will utilise the investment to develop an athlete management platform with an inspiring infographic, reporting and sell licences to access the platform's suite of online tools.
days to go:
Expired
investment:
£57,580
Greenwall Environmental Group is a company engaged in making devices that can minimise non-biodegradable waste. It argues that asbestos remains the largest occupational killer in the UK today. Its product, Asbestosprobe, aims to change this situation. The company asserts that Asbestoprobe is arguably the world's first handheld analyser specifically designed to detect asbestos in real-time. It argues that current methods of detecting and recording the presence of asbestos are costly, invasive and slow. Asbestoprobe uses a point-and-click approach utilising NIR Spectroscopy and Artificial Intelligence (AI) to analyse the presence of asbestos in two minutes via the Asbestoprobe App. Greenwall plans to provide an annual software licensing model which grows through recurring revenue year on year. It endeavours to be a segment leader in the projected $1 billion global asbestos management market. The company will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£253,017
WELD is a fitness company on a mission to make on-demand health, fitness and wellbeing available to all ages & abilities. The company allows users and instructors to set the time and place for the training session, rent out their home or commercial spaces for activities, or interact 1-2-1 online. This approach, the company believes, helps personal trainers, hit by the Covid-19 lockdown, find clients. WELD also allows trainers to set their prices and keep 90% of their fees, and lets customers enjoy a 2% commission on referrals for every future session taken in perpetuity. WELD aims to tap into the $94 billion global fitness and wellness market that grew 8.7% from 2018/19. The company's primary target audience is Generation Z that, the company believes, embraced wellness. WELD will use the investment to improve its platform, boost marketing and plug the fitness & wellness gap.
days to go:
Expired
investment:
£199,227
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.
days to go:
Expired
investment:
£270,543
Her.9 is a Direct-To-Consumer (DTC) female technology brand that caters to the needs of women during pregnancy. It cites research arguing that up to 40% of women taking prenatal vitamins may not be able to absorb the folic acid within the UK’s leading pregnancy brand. Her.9 aims to resolve this by employing DUOCAP technology. The company asserts that DUOCAP is a capsule-in-capsule delivery system which contains solubilised prebiotics in the outer capsule and probiotics in the inner capsule. The prebiotic releases immediately and the probiotic releases later allowing for targeted supplement delivery in the body. The prenatal supplements market is set to be worth $56 billion globally by 2024. Her.9 aims to be a notable contender in this segment. The company is raising investment to build its already established partnerships and execute its marketing strategy effectively.
days to go:
Expired
investment:
£215,946
